Efficacy of Ayurveda Interventions(Pushkar Guggulu and Haritaki) as add-on to Standard Care in Stable Coronary Artery Disease: A Double-blind Randomized Controlled Study - Not applicable

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1. Clinically diagnosed and confirmed cases of stable coronary artery disease such as already Angiographically documented one two or three vessel coronary disease
•2. If not Confirmation of CAD may be done by any of the following Exercise stress testing or pharmacologic stress testing or an anatomic assessment of the coronary arteries or either with coronary computed tomography angiography (CTA) or an invasive coronary angiogram as and when required
•3. Willing to be a part of the study

•1. Patients having IHD with specific conditions like acute myocardial infarction unstable angina pectoris congenital anomalies valvular diseases hypertrophic cardiomyopathies and congestive cardiac failure
•2. History of PTCA or CABG within 90 days
•History of Renal dysfunction (Sr creatinine 1.2 mg%) chronic kidney disease GFR less than 60 ml per min
•3. History of active liver disease
•Patients with poorly controlled Hypertension more than 160 by 100 mm of Hg and Patients with poorly controlled Diabetes Mellitus HbA1c more than 8.0 percent
•4. Active liver disease AST and ALT, total bilirubin, ALP more than 2 times upper normal limit
•5. Pulmonary dysfunction COPD CVA Psychiatric illness malignancy etc.
•6. Patients on prolonged more than 6 weeks medication with corticosteroids or antidepressants or anti-cholinergics etc or any other drugs that may have an influence on the outcome on the study
•7. Participants who were tested COVID 19 positive through a positive RT PCR in the last 30 days
•8. Participants with Post COVID 19 complications or BP fluctuations following disease
•9. History of hypersensitivity towards the trial drug or any ingredient
•10. History of substance abuse or alcohol intake
•11. Pregnant or lactating women
•12. Any other condition which the PI thinks may jeopardize the safety of the patients

发起方